Gene · 8767
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and Validation of Inflammatory Response-Related Gene Signatures to Predict the Prognosis of Neuroblastoma. | Int J Genomics | 2022 | 35535346 | PubTator, text mining | PubMed |
| Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation. | Front Microbiol | 2022 | 35531300 | PubTator, text mining | PubMed |
| Preksha Dhyāna meditation induces alterations at the transcriptome level in novice and healthy college students. | Saudi J Biol Sci | 2022 | 35531197 | PubTator, text mining | PubMed |
| Disorders of ubiquitylation: unchained inflammation. | Nat Rev Rheumatol | 2022 | 35523963 | PubTator, text mining | PubMed |
| SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination. | Clin Immunol | 2022 | 35513305 | PubTator, text mining | PubMed |
| Identification of shared loci associated with both Crohn's disease and leprosy in East Asians. | Hum Mol Genet | 2022 | 35512355 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction. | Mol Med | 2022 | 35508972 | PubTator, text mining | PubMed |
| Signaling Pathway and Small-Molecule Drug Discovery of FGFR: A Comprehensive Review. | Front Chem | 2022 | 35494629 | PubTator, text mining | PubMed |
| High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer. | J Ovarian Res | 2022 | 35477477 | PubTator, text mining | PubMed |
| A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours. | BMC Med Genomics | 2022 | 35473583 | PubTator, text mining | PubMed |
| An Overview of Autophagy in Helicobacter pylori Infection and Related Gastric Cancer. | Front Cell Infect Microbiol | 2022 | 35463631 | PubTator, text mining | PubMed |
| Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients. | Front Public Health | 2022 | 35462848 | PubTator, text mining | PubMed |
| A new horizon of precision medicine: combination of the microbiome and extracellular vesicles. | Exp Mol Med | 2022 | 35459887 | PubTator, text mining | PubMed |
| Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions. | Cells | 2022 | 35456016 | PubTator, text mining | PubMed |
| Monocytes and macrophages in pregnancy: The good, the bad, and the ugly. | Immunol Rev | 2022 | 35451089 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| XIAP promotes melanoma growth by inducing tumour neutrophil infiltration. | EMBO Rep | 2022 | 35437868 | PubTator, text mining | PubMed |
| Identification of an Immune Classification and Prognostic Genes for Lung Adenocarcinoma Based on Immune Cell Signatures. | Front Med (Lausanne) | 2022 | 35433762 | PubTator, text mining | PubMed |
| Immunomodulation as a Protective Strategy in Chronic Otitis Media. | Front Cell Infect Microbiol | 2022 | 35433505 | PubTator, text mining | PubMed |
| Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma. | Front Oncol | 2022 | 35433463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8767/papers?page=28